TF and B-cell chronic lymphocytic leukemia: Based on the SE modeling and TF assessments, CRCs and master TFs have been defined in chronic lymphocytic leukemia (45), lung adenocarcinoma (46), and esophageal squamous cell carcinoma (47, 48).